FREEDOM Trial’s Data Favors CABG Over PCI For Patients With Diabetes
This article was originally published in The Gray Sheet
Executive Summary
Patients in the trial showed significantly reduced rates in the composite outcome of death, heart attacks and strokes after five years with CABG versus percutaneous coronary intervention.
You may also be interested in...
Large ASCERT Observational Study Favors CABG Over PCI
Bypass graft surgery had a relative risk reduction of about 20% long term compared to stenting.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.